These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7578896)

  • 1. Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.
    Avellone G; Di Garbo V; Cordova R; Piliego T; Raneli G; De Simone R; Bompiani GD
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):543-8. PubMed ID: 7578896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic response in subjects with hypertriglyceridemia and low HDL cholesterol.
    Cimminiello C; Vigorelli P; Piliego T; Soncini M; Toschi V; Arpaia G; Perolini S; Bonfardeci C
    Biomed Pharmacother; 1997; 51(4):164-9. PubMed ID: 9207984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gemfibrozil on the regulation of HDL subfractions in hypertriglyceridaemic patients.
    Kahri J; Sane T; van Tol A; Taskinen MR
    J Intern Med; 1995 Nov; 238(5):429-36. PubMed ID: 7595182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels.
    Bröijersen A; Eriksson M; Wiman B; Angelin B; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):511-6. PubMed ID: 8624772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
    Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
    Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB; Donega P; Passaro A; Zanca R; Cattin L; Fonda M; Pauciullo P; Marotta G; Fellin R; Gasparrini S; Piliego T
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
    J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100.
    Ridker PM; Vaughan DE; Stampfer MJ; Sacks FM; Hennekens CH
    Arterioscler Thromb; 1993 Nov; 13(11):1587-92. PubMed ID: 8218099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemfibrozil treatment of hypertriglyceridemia: improvement on fibrinolysis without change of insulin resistance.
    Jeng JR; Jeng CY; Sheu WH; Lee MM; Huang SH; Shieh SM
    Am Heart J; 1997 Sep; 134(3):565-71. PubMed ID: 9327717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemfibrozil predictably lowers triglycerides but does not significantly change plasminogen activator inhibitor activity in hypertriglyceridemic patients with a history of thrombosis.
    Haire WD
    Thromb Res; 1991 Nov; 64(4):493-501. PubMed ID: 1788834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels.
    Mänttäri M; Koskinen P; Manninen V; Huttunen JK; Frick MH; Nikkilä EA
    Atherosclerosis; 1990 Feb; 81(1):11-7. PubMed ID: 2407250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels.
    Schaefer EJ; Lamon-Fava S; Cole T; Sprecher DL; Cilla DD; Balagtas CC; Rowan JP; Black DM
    Atherosclerosis; 1996 Nov; 127(1):113-22. PubMed ID: 9006811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
    J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study.
    Insua A; Massari F; Rodríguez Moncalvo JJ; Rubén Zanchetta J; Insua AM
    Endocr Pract; 2002; 8(2):96-101. PubMed ID: 11942772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes induced by gemfibrozil on lipidic, coagulative and fibrinolytic pattern in patients with type IV hyperlipoproteinemia.
    Avellone G; Di Garbo V; Panno AV; Cordova R; Lepore R; Strano A
    Int Angiol; 1988; 7(3):270-7. PubMed ID: 3198979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients.
    Mussoni L; Mannucci L; Sirtori C; Pazzucconi F; Bonfardeci G; Cimminiello C; Notarbartolo A; Scafidi V; Bittolo Bon G; Alessandrini P; Nenci G; Parise P; Colombo L; Piliego T; Tremoli E
    Atherosclerosis; 2000 Feb; 148(2):397-406. PubMed ID: 10657576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of gemfibrozil on the concentration and composition of very low density and low density lipoprotein subfractions in hypertriglyceridemic patients.
    Dachet C; Cavallero E; Martin C; Girardot G; Jacotot B
    Atherosclerosis; 1995 Feb; 113(1):1-9. PubMed ID: 7755644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
    Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
    Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.